Reduced Susceptibility to Praziquantel among Naturally Occurring Kenyan Isolates of Schistosoma mansoni

BACKGROUND: The near exclusive use of praziquantel (PZQ) for treatment of human schistosomiasis has raised concerns about the possible emergence of drug-resistant schistosomes. METHODOLOGY/PRINCIPAL FINDINGS: We measured susceptibility to PZQ of isolates of Schistosoma mansoni obtained from patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Melman, Sandra D., Steinauer, Michelle L., Cunningham, Charles, Kubatko, Laura S., Mwangi, Ibrahim N., Wynn, Nirvana Barker, Mutuku, Martin W., Karanja, Diana M. S., Colley, Daniel G., Black, Carla L., Secor, William Evan, Mkoji, Gerald M., Loker, Eric S.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721635/
https://www.ncbi.nlm.nih.gov/pubmed/19688043
http://dx.doi.org/10.1371/journal.pntd.0000504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721635/
https://www.ncbi.nlm.nih.gov/pubmed/19688043
http://dx.doi.org/10.1371/journal.pntd.0000504

Ejemplares similares